Summary
The occurrence of antilymphocyte antibodies (AL-Ab) was investigated in the sera of 28 patients with scleroderma. By indirect immunofluorescence, we found these Ab in 53% of the sera. Inhibition of E rosette formation and lymphocytotoxicity revealed these Ab in 42% and 14% of the sera respectively. Most of the Ab (93%) reacted at 0°C. These AL-Ab can be separated into several groups depending on their inhibitory activity on the lymphocyte membrane. In some cases, the receptor seems similar to that of sheep red blood cells. The study of the clinical features of the patients showed few differences between the groups with and those without Al-Ab. It must be noted that all the patients with the CREST syndrome (6 cases) possessed Al-Ab.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baron, M., Keystone, E.C., Gladman, D.D., Lee, P., Poplonski, L. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma. Clin Exp Immunol. 1981, 46, 70–76.
Markenson, J., Lockshin, M., Rosenfeld, B. Lymphocytes hyporesponsiveness to PHA in patients with progressive sclerosis: role of monocytes. Arthritis Rheum, 1979, 22, 637–638.
Hughes, P., Holt, S., Powel, N.R., Dodd, J. Thymus dependent (T) lymphocyte deficiency in progressive systemic sclerosis. Br J Dermatol, 1976, 95, 169–173.
Horwitz, D.A., Juul-Nielsen, K. Human blood lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells. Clin Exp Immunol, 1977, 30, 370–378.
Inoshita, T., Whiteside, T.L., Rodnan, G.P., Taylor, F.H. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (P.S.S., Scleroderma). J Lab Clin Med, 1981, 97, 264–277.
Krakhauer, R.S., Sundeen, J., Sauder, D.N., Scherbel, A. Abnormalities of immunoregulation in progressive systemic sclerosis evidence for excess helper-cell function and altered B-cell function. Arch Dermatol, 1981, 117, 80–82.
Keystone, E.C., Lau, C., Gladman, D.D., Wilkinson, S., Lee, P., Shore, A. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol, 1982, 48, 443–448.
Bernstein, R.M., Steigerwald, J.C., Tan, E.M. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol. 1982, 48, 43–51.
Moroi, Y., Peebles, C., Fritzler, M., Steigerwald, J.C., Tan, E.M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA. 1980, 77, 1627–16.
Fritzler, M.J., Kinsella, T.D., Garbutt, E. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med, 1980, 69, 520–526.
Douvas, A.S., Achten, M., Tan, E.M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem, 1979, 254, 10514–10522.
Horwitz, D.A., Garrett, M.A., Craig, A.H. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol, 1977, 27, 100–110.
Cormane, R.H., Hamerlinck, F., Nunzi, E. Antibodies eluted from lymphoid cell membrane. Occurrence in certain varieties of scleroderma. Arch Dermatol, 1979, 115, 709–712.
Pruzanski, W., Lee, P., Wilshire, A., Gladman, D., Keystone, E.C. Lymphocytotoxic and phagocytotoxic activity in progressive systemic sclerosis. J Rheumatol, 1983, 10 (1), 55–60.
Labro, M.T., Périanin, A., Kahn, M.F. Antilymphocyte antibodies in progressive systemic sclerosis. Clin Exp Rheum, 1982, 1, 23–28.
Beverley, P.C.L., Callard, R.E. Distinctive functional characteristics of human T lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol, 1981, 11, 329–334.
Burns, G.F., Boyd, A.W., Beverley, P.C. Two monoclonal antihuman T lymphocyte antibodies have similar biological effects and recognize the same cell surface antigen. J Immunol, 1982, 129, 1451–1457.
Chang, T.W., Kung, P.C., Gingras, S.P., Goldstein, G. Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells? Proc Natl Acad Sci USA. 1981, 78 (3), 1805–1808.
Kahaleh, M.B., Sherer, G.K., Leroy, E. Endothelial injury in scleroderma. J Exp Med, 1979, 149, 1326.
Meyer, O., Haïm, T., Dryll, A., Lansaman, J., Ryckewaert, A. Vascular endothelial cell injury in progressive systemic sclerosis and other connective tissue diseases. Clin Exp Rheumatol, 1983, 1, 29–34.
Kahaleh, M.B., Leroy, E.C. Endothelial injury in scleroderma. A protease mechanism. J Lab Clin Med. 1983, 101, 553–560.
Kamoun, M., Martin, P.J., Hansen, J.A., Brown, M.A., Siadak, A.W., Nowinski, R.C. Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med, 1981, 153, 207.
Boumsell, L., Bernard, A. Surface antigens on malignant T-cells, in Leukemia Marker Conference, 1981, W. Knapp, Editor. Springer-Verlag Heidelberg, 129–141.
Bernard, A., Gelin, C., Raynal, B., Pham, D., Gosse, C., Boumsell, L. Phenomenon of human T cells rosetting with sheep erythrocyte analyzed with monoclonal antibodies. J Exp Med, 1982, 155, 1317–1333.
Mitsuki, N., Kashiwazaki, S., Tazaki, Y. IgG antilymphocyte antibody in systemic lupus erythematosus. XVth International Congress of Rheumatology, Paris. Abstract 450 in Rev Rhum, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Labro, M.T., Perianin, A. & Kahn, M.F. Detection of antilymphocyte antibodies in patients with scleroderma using three different techniques. Clin Rheumatol 3, 435–441 (1984). https://doi.org/10.1007/BF02031265
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02031265